BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Leen Rigouts"”

16+ results

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

Verified

Karine Brudey, Jeffrey Driscoll, Leen Rigouts, Wolfgang M. Prodinger et al.

Journal: BMC MicrobiologyYear: 2006Citations: 1035

BACKGROUND: The Direct Repeat locus of the Mycobacterium tuberculosis complex (MTC) is a member of the CRISPR (Clustered regularly interspaced short palindromic repeats) sequences family. Spoligotyping is the widely used PCR-based reverse-hybridization blotting technique that assays the genetic dive...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard

Verified

Armand Van Deun, K. J. M. Aung, Valentin Bola, Rossin Lebeke et al.

Journal: Journal of Clinical MicrobiologyYear: 2013Citations: 244

The rapid diagnosis of rifampin resistance is hampered by a reported insufficient specificity of molecular techniques for detection of rpoB mutations. Our objective for this study was to document the prevalence and prognostic value of rpoB mutations with unclear phenotypic resistance. The study desi...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

Verified

Matteo Zignol, Anna Dean, Natavan Alikhanova, Sönke Andres et al.

Journal: The Lancet Infectious DiseasesYear: 2016Citations: 165

BACKGROUND: Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is available. METHODS: In a molecular epidemiology analysis, we used population-bas...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

Verified

Matteo Zignol, Andrea Maurizio Cabibbe, Anna Dean, Philippe Glaziou et al.

Journal: The Lancet Infectious DiseasesYear: 2018Citations: 160

BACKGROUND: In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis drugs is hampered by the limitations of phenotypic testing for drug susceptibility. We therefore evaluated the use of genetic sequencing for surveillance of drug resistance in tuberculosis. METHODS:...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Disputed <I>rpo</I>B mutations can frequently cause important rifampicin resistance among new tuberculosis patients

Verified

Armand Van Deun, K. J. M. Aung, Md Anwar Hossain, Pim de Rijk et al.

Journal: The International Journal of Tuberculosis and Lung DiseaseYear: 2015Citations: 98

SETTING: Greater Mymensingh area, Bangladesh. OBJECTIVES: To document among new tuberculosis (TB) patients the proportions and treatment outcomes of silent, non-disputed and disputed (generally missed by rapid drug susceptibility testing [DST]) rpoB mutations, and their detection by commercial molec...

Health SciencesMedicineInfectious Diseases
Read Source

Genotypic and Phenotypic Heterogeneity among<i>Mycobacterium tuberculosis</i>Isolates from Pulmonary Tuberculosis Patients

Verified

Isdore Chola Shamputa, Leen Rigouts, Lovet Achale Eyongeta, Nabil Abdullah El Aila et al.

Journal: Journal of Clinical MicrobiologyYear: 2004Citations: 97

Although the heterogeneity of Mycobacterium tuberculosis populations and the existence of mixed infections are now generally accepted, systematic studies on their relative importance are rare. In the present study, 10 individual colonies of each M. tuberculosis isolate (primary isolate) from 97 tube...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Specific<i>gyrA</i>gene mutations predict poor treatment outcome in MDR-TB

Verified

Leen Rigouts, Nele Coeck, Mourad Gumusboga, Willem Bram de Rijk et al.

Journal: Journal of Antimicrobial ChemotherapyYear: 2015Citations: 95

OBJECTIVES: Mutations in the gyrase genes cause fluoroquinolone resistance in Mycobacterium tuberculosis. However, the predictive value of these markers for clinical outcomes in patients with MDR-TB is unknown to date. The objective of this study was to determine molecular markers and breakpoints pr...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains

Verified

Simone Battaglia, Andrea Spitaleri, Andrea Maurizio Cabibbe, Conor J. Meehan et al.

Journal: Journal of Clinical MicrobiologyYear: 2020Citations: 68

The role of mutations in genes associated with phenotypic resistance to bedaquiline (BDQ) and delamanid (DLM) in Mycobacterium tuberculosis complex (MTBc) strains is poorly characterized. A clear understanding of the genetic variants’ role is crucial to guide the development of molecular-based drug ...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens.

Verified

Armand Van Deun, K. J. M. Aung, Subhadeep Chowdhury, Shyama Prasad Saha et al.

Journal: PubMedYear: 1999Citations: 26

SETTING: Greater Mymensingh District, a rural area of Bangladesh, at the start of the National Tuberculosis Programme (NTP). OBJECTIVES: To determine the prevalence of initial and acquired drug resistance of Mycobacterium tuberculosis, and to assess the appropriateness of the NTP's standard regimens...

Health SciencesMedicineInfectious Diseases
Read Source

<i>Mycobacterium tuberculosis</i>borderline<i>rpoB</i>mutations: emerging from the unknown

Verified

Armand Van Deun, Tom Decroo, K. J. M. Aung, M. Anwar Hossain et al.

Journal: European Respiratory JournalYear: 2021Citations: 23

<b>Despite their name, borderline <i>rpoB</i> mutations are correlated with unfavourable outcomes when rifampicin-throughout treatment is used. They may become the drivers of rifampicin-resistant tuberculosis. Second-line treatment is recommended.</b> https://bit.ly/3nbkZjt

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Assessment of Population Structure and Major Circulating Phylogeographical Clades of <i>Mycobacterium tuberculosis</i> Complex in Bangladesh Suggests a High Prevalence of a Specific Subclade of Ancient <i>M. tuberculosis</i> Genotypes

Verified

Zeaur Rahim, Khadiza Zaman, Adri G. M. van der Zanden, Marius J. Möllers et al.

Journal: Journal of Clinical MicrobiologyYear: 2007Citations: 23

ABSTRACT Spoligotyping was performed to study the population structure of Mycobacterium tuberculosis complex strains ( n = 224) from Bangladesh. Strains were split into principal genetic group 1 (PGG 1 [75.0%]) and PGG 2 and 3 (25%). Forty-nine strains with a new spoligotype signature and considered...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Drug resistance monitoring: combined rates may be the best indicator of programme performance.

Verified

Armand Van Deun, AFM Salim, Paul Daru, Ananya Das et al.

Journal: PubMedYear: 2004Citations: 21

SETTING: Greater Mymensingh District, Bangladesh. OBJECTIVES: To determine changes in prevalence of drug resistance of Mycobacterium tuberculosis under DOTS. DESIGN: Drug susceptibility testing of systematic samples of M. tuberculosis isolated from all sputum smear-positive cases newly registered in...

Health SciencesMedicineInfectious Diseases
Read Source

Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection

Verified

Isdore Chola Shamputa, Armand Van Deun, Md Abdul Hamid Salim, Md Anwar Hossain et al.

Journal: Tropical Medicine & International HealthYear: 2007Citations: 19

OBJECTIVE: To determine the relative frequencies of reinfection vs. reactivation or treatment failure in patients from a high tuberculosis incidence setting with a low prevalence of HIV infection. METHOD: We performed DNA fingerprinting on serial isolates from one and multiple TB episodes from 97 re...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen

Verified

Pauline Lempens, Tom Decroo, K. J. M. Aung, Mohammad Anwar Hossain et al.

Journal: International Journal of Infectious DiseasesYear: 2020Citations: 15

OBJECTIVES: We investigated whether companion drug resistance was associated with adverse outcomes of the shorter multidrug-resistant tuberculosis (MDR-TB) treatment regimen in Bangladesh after adjustment for fluoroquinolone resistance. METHODS: MDR-TB/rifampicin-resistant tuberculosis patients regi...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout

Verified

K. J. M. Aung, Erik De Clercq, Md. A. Ali, Sowjanya Naha et al.

Journal: The International Journal of Tuberculosis and Lung DiseaseYear: 2012Citations: 14

SETTING: Damien Foundation tuberculosis (TB) control projects in Bangladesh. OBJECTIVE: To assess the effectiveness of extending the intensive phase (P1) of treatment by 1 month for patients who are smear-positive after 2 months of a 6-month regimen containing rifampicin (RMP) throughout. DESIGN: Pr...

Health SciencesMedicineInfectious Diseases
Read Source
PreviousPage 1 of 2+Next